Close
Login to MyACC
ACC Members


Not a Member?

The Association of Corporate Counsel (ACC) is the world's largest organization serving the professional and business interests of attorneys who practice in the legal departments of corporations, associations, nonprofits and other private-sector organizations around the globe.

Join ACC

ACC Member Portal and Web Services are back online
ACC's member portal and web services are available following a scheduled upgrade. However, our team is monitoring and resolving issues promptly. Please be sure to reset your password here.
Thank you for your patience. Please contact our team with any questions.

Search Filters
Jennifer F. Walsh, Kate M. Kros, John R. West, Foley & Lardner
4 pages

Read this article from Foley & Lardner to find out how President Biden's Inflation Reduction Act affects the healthcare industry.

Resource Details
Interest Area: Health Law
Region: United States
Audience: Mid-Career, New to In-House, Small Law Departments, Large Law Departments
Pamela L. Johnston, Judith A. Waltz, Foley & Lardner
2 pages

On August 17, 2022, the Centers for Medicare and Medicaid Services (CMS) issued a bulletin (Bulletin) to states addressing potentially inappropriate cost-based proposals and practices related to governmental ambulance providers in the delivery of ground emergency medical transportation to Medicaid beneficiaries (GEMT). Check out this article by Foley & Lardner detailing the CMS bulletin.

Resource Details
Interest Area: Health Law
Audience: Mid-Career, New to In-House, Small Law Departments, Large Law Departments
Diane Hazel, Foley & Lardner
2 pages

On August 15, 2022, the Federal Trade Commission (FTC)—in a bipartisan, 5-0 vote—issued a policy paper detailing its concerns with Certificates of Public Advantage (COPAs). Check out this article by Foley & Lardner article detailing the policy paper and the future of the FTC and COPAs.

Resource Details
Interest Area: Health Law
Region: United States
Audience: Mid-Career, New to In-House, Small Law Departments, Large Law Departments
Devaki Patel, Kyle Y. Faget, Monica R. Chmielewski, David L. Rosen, Foley & Lardner LLP
2 pages

Check out this article by Foley & Lardner in response to an unprecedented move by the U.S. Food and Drug Administration (FDA or Agency) detailing a warning letter sent to Amazon.com, Inc. (Amazon), a fulfillment house, with respect to distributing over-the-counter (OTC) drug products that are in violation of the Federal Food, Drug, and Cosmetic Act (FD&C Act).

Resource Details
Interest Area: Health Law
Audience: Mid-Career, New to In-House, Small Law Departments, Large Law Departments
Alexandra Busto, Jill H. Gordon, Michele A. Masucci, Morgan C. Nighan, and Rebecca Simone, Nixon Peabody
6 pages

This article provides key considerations for telehealth providers in mapping out how to deliver care on a multi-state basis in light of the Dobbs decision and related state legislation.

Resource Details
Interest Area: Health Law
Region: United States
Foley & Lardner LLP
44 pages

Check out this whitepaper developed by Foley & Lardner LLP to learn more about the top twelve trends in the digital assets space.

Resource Details
Region: United States
Audience: Mid-Career, New to In-House, Small Law Departments, Large Law Departments
Foley & Lardner LLP
32 pages

Check out this resource developed by Foley & Lardner LLP that focuses on the top seventeen trends for the health & life sciences sector in 2022.

Resource Details
Interest Area: Health Law
Region: United States
Audience: Mid-Career, New to In-House, Small Law Departments, Large Law Departments
AGENDA:
  • 9:00 a.m. to 10:00 a.m. - Session I (Shook, Hardy & Bacon L.L.P.)

  • 10:00 a.m. to 10:30 a.m. - BREAK

  • 10:30 a.m. to 11:30 a.m. - Session II (McCarter & English, LLP)


Session I — Current Antitrust Issues For Health, Biotech, and Pharmaceutical Companies

The DOJ, FTC, and many state AGs are all promising a dramatic expansion of antitrust enforcement, and legislation that would overhaul existing antitrust laws is before Congress.  This session will discuss the possible impact of the current enforcement environment on health, biotech, and pharma companies.  We will discuss recent cases and policy statements as well as where enforcers might go next.

Session II — Ensuring Pharmaceutical Company Compliance with Updated PhRMA and FDA Guidelines

The year 2021 saw revisions to the PhRMA Code as well as new FDA guidance regarding off-label promotion.  In this program, speakers from McCarter and English and Endo Pharmaceuticals Inc. will discuss these updates and provide guidance on how pharmaceutical companies can navigate these changes and remain compliant.

Use the red Register button to RSVP.  The Zoom link will be provided with your completed registration, and is also shown below.

 

https://accinhouse.zoom.us/j/95756219631

Thomas B. Ferrante, Nathaniel M. Lacktman, Rachel B. Goodman, Foley & Lardner
4 pages

On July 7, 2022, the Centers for Medicare & Medicaid Services (CMS) proposed five new changes to Remote Therapeutic Monitoring (RTM) services under the Medicare program. The changes are part of the proposed 2023 Medicare Physician Fee Schedule rule. To learn more check out this Foley & Lardner article.

Resource Details
Interest Area: Health Law
Region: United States
Audience: Mid-Career, New to In-House, Small Law Departments, Large Law Departments
Rachel B. Goodman, Nathaniel M. Lacktman, Thomas B. Ferrante, Foley & Lardner
5 pages

On July 7, 2022, the Centers for Medicare and Medicaid Services (CMS) released its proposed 2023 Medicare Physician Fee Schedule (PFS) rule. Learn more about this rule by checking out this article released by Foley and Lardner.

Resource Details
Interest Area: Health Law
Audience: Mid-Career, New to In-House, Small Law Departments, Large Law Departments
Subscribe to Health Law